143 related articles for article (PubMed ID: 16376805)
1. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab.
Argyropoulou MI; Glatzouni A; Voulgari PV; Xydis VG; Nikas SN; Efremidis SC; Drosos AA
Joint Bone Spine; 2005 Dec; 72(6):557-61. PubMed ID: 16376805
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab.
Zikou AK; Argyropoulou MI; Voulgari PV; Xydis VG; Nikas SN; Efremidis SC; Drosos AA
J Rheumatol; 2006 Feb; 33(2):219-23. PubMed ID: 16465650
[TBL] [Abstract][Full Text] [Related]
3. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
4. Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation.
Tam LS; Griffith JF; Yu AB; Li TK; Li EK
Clin Rheumatol; 2007 Jun; 26(6):941-6. PubMed ID: 16868816
[TBL] [Abstract][Full Text] [Related]
5. Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging.
Hirose W; Nishikawa K; Hirose M; Nanki T; Sugimoto H
Mod Rheumatol; 2009; 19(1):20-6. PubMed ID: 18762862
[TBL] [Abstract][Full Text] [Related]
6. Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period.
Voulgari PV; Alamanos Y; Drosos AA
Curr Clin Pharmacol; 2006 Jan; 1(1):103-8. PubMed ID: 18666381
[TBL] [Abstract][Full Text] [Related]
7. Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis.
Temekonidis TI; Georgiadis AN; Alamanos Y; Bougias DV; Voulgari PV; Drosos AA
Ann Rheum Dis; 2002 Sep; 61(9):822-5. PubMed ID: 12176808
[TBL] [Abstract][Full Text] [Related]
8. Persistent low grade synovitis without erosive progression in magnetic resonance imaging of rheumatoid arthritis patients treated with infliximab over 1 year.
Fonseca JE; Canhão H; Tavares NJ; Cruz M; Branco J; Queiroz MV
Clin Rheumatol; 2009 Oct; 28(10):1213-6. PubMed ID: 19504146
[TBL] [Abstract][Full Text] [Related]
9. Infliximab therapy in established rheumatoid arthritis: an observational study.
Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
[TBL] [Abstract][Full Text] [Related]
10. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
Saougou I; Markatseli TE; Papagoras C; Voulgari PV; Alamanos Y; Drosos AA
Semin Arthritis Rheum; 2011 Apr; 40(5):398-406. PubMed ID: 20843542
[TBL] [Abstract][Full Text] [Related]
11. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study.
Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Bonnet V; Beckers C; Malaise MG
Radiology; 2003 Nov; 229(2):562-9. PubMed ID: 12970463
[TBL] [Abstract][Full Text] [Related]
13. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging: a valuable method for the detection of synovial inflammation in rheumatoid arthritis.
Goupille P; Roulot B; Akoka S; Avimadje AM; Garaud P; Naccache L; Le Pape A; Valat JP
J Rheumatol; 2001 Jan; 28(1):35-40. PubMed ID: 11196540
[TBL] [Abstract][Full Text] [Related]
15. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
[TBL] [Abstract][Full Text] [Related]
16. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
Haavardsholm EA; Østergaard M; Hammer HB; Bøyesen P; Boonen A; van der Heijde D; Kvien TK
Ann Rheum Dis; 2009 Oct; 68(10):1572-9. PubMed ID: 19019893
[TBL] [Abstract][Full Text] [Related]
17. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
[TBL] [Abstract][Full Text] [Related]
18. Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects.
Iannone F; Trotta F; Montecucco C; Giacomelli R; Galeazzi M; Matucci-Cerinic M; Ferri C; Cutolo M; Maria Bambara L; Triolo G; Ferraccioli G; Valentini G; Lapadula G;
Ann Rheum Dis; 2007 Feb; 66(2):249-52. PubMed ID: 16837489
[TBL] [Abstract][Full Text] [Related]
19. Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist.
Bao J; Yue T; Li T; He DY; Bao YX
Int J Rheum Dis; 2016 Apr; 19(4):370-6. PubMed ID: 24798350
[TBL] [Abstract][Full Text] [Related]
20. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
